BioGaia AB logo

BioGaia AB

BGLAF · OTC · Health Technology, Pharmaceuticals: Other · Founded 1990

BioGaia AB engages in the development, marketing, and sale of probiotic products. It operates through the following segments: Pediatrics, Adult Health, and Other. The Pediatrics segment sells drops, oral rehydration solutions, digestive health tablets, and also royalties pertaining to pediatric products.

Current Price
$11.55
Market Cap
$1.2B
Return Since Last Split
+2426%
Last Split
May 18, 2022
Total Splits
1
Cumulative Multiple
5×

What If You Bought BGLAF Earlier?

Investment
Purchase Date (Before Split)
Worth Today
$5,775
500 shares · 5×

Estimate based on split history only. Excludes dividends, fees, taxes, and intraday movement.

Stock Split History

Newest split first. Cumulative multiple = compounded growth within the displayed company lineage.

Split DatePrice BeforeRatioSplit MultipleCumulative
May 18, 2022$11.325-for-15×5×

BioGaia AB Market Cap Timeline

A validated annual market-cap history is unavailable from the current sources. The current market-cap snapshot, when shown above, is not treated as historical evidence. Split markers cover 1 current-security split. Filled dots have market-cap data for that year; hollow dots mark split years outside market-cap source coverage.

Validated annual history unavailable

At least two source-validated annual observations are required before this page draws a market-cap timeline. A current snapshot is not treated as historical trend data.

Recorded split dates

Frequently Asked Questions

BioGaia AB's latest record in the split calendar is a 5-for-1 forward split effective 2022-05-18.
Stay in the loop

Never Miss a Stock Split Again

Get personalized stock split alerts. Choose what you receive and how often.

Your email is securely stored. We’ll only contact you about updates you choose. Unsubscribe anytime.